Literature DB >> 11424953

The rapid effects of estrogen are implicated in estrogen-mediated neuroprotection.

N Linford1, C Wade, D Dorsa.   

Abstract

A review of the literature reveals an impressively broad spectrum of effects of the hormone estrogen in the CNS. One of the more recently documented is the ability of estrogen to protect neurons from cell death associated with a variety of insults. While some of these actions can be attributed to nuclear effects of the hormone, mediated by the estrogen receptors alpha and/or beta, an increasing number of these effects appear to result from actions of the hormone mediated by signal transduction pathways traditionally associated with activation of membrane receptors. Here, we review current findings on actions of estrogen mediated by two pathways: those dependent on cAMP and Protein Kinase A, and those related to activation of the Mitogen Acivated Protein Kinase cascade. The evidence that estrogen can rapidly activate either pathway, and the potential involvement of the estrogen receptors alpha or beta acting in the vicinity of the cell membrane will be discussed. The possible role of MAP-Kinase activation and BCL-2 induction in the phenomenon of estrogen-neuroprotection will also be addressed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11424953     DOI: 10.1023/a:1007113323582

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  10 in total

Review 1.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

2.  17α-estradiol attenuates neuron loss in ovariectomized Dtg AβPP/PS1 mice.

Authors:  Kebreten F Manaye; Joanne S Allard; Sara Kalifa; Amy C Drew; Guang Xu; Donald K Ingram; Rafael de Cabo; Peter R Mouton
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  17alpha-Estradiol is neuroprotective in male and female rats in a model of early brain injury.

Authors:  Jacob McClean; Joseph L Nuñez
Journal:  Exp Neurol       Date:  2007-10-10       Impact factor: 5.330

4.  17beta-estradiol protects the neonatal brain from hypoxia-ischemia.

Authors:  Joseph Nuñez; Zhengang Yang; Yuhui Jiang; Theresa Grandys; Ilana Mark; Steven W Levison
Journal:  Exp Neurol       Date:  2007-09-12       Impact factor: 5.330

Review 5.  Rapid and estrogen receptor beta mediated actions in the hippocampus mediate some functional effects of estrogen.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Steroids       Date:  2008-02-09       Impact factor: 2.668

6.  ESTROGEN REPLACEMENT THERAPY FOR STROKE.

Authors:  Mibel Pabon; Cyrus Tamboli; Sarosh Tamboli; Sandra Acosta; Ike De La Pena; Paul R Sanberg; Naoki Tajiri; Yuji Kaneko; Cesar V Borlongan
Journal:  Cell Med       Date:  2014-04-10

Review 7.  Estrogen and selective estrogen receptor modulators: neuroprotection in the Women's Health Initiative era.

Authors:  Stephanie Murphy; Louise McCullough; Marguerite Littleton-Kearney; Patricia Hurn
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

8.  Estrogen induces rapid translocation of estrogen receptor beta, but not estrogen receptor alpha, to the neuronal plasma membrane.

Authors:  L C Sheldahl; R A Shapiro; D N Bryant; I P Koerner; D M Dorsa
Journal:  Neuroscience       Date:  2008-02-29       Impact factor: 3.590

9.  Estradiol differentially regulates lipocalin-type prostaglandin D synthase transcript levels in the rodent brain: Evidence from high-density oligonucleotide arrays and in situ hybridization.

Authors:  Jessica A Mong; Nino Devidze; Donald E Frail; Lawrence T O'Connor; Manjo Samuel; Elena Choleris; Sonoko Ogawa; Donald W Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

10.  Synergistic Action of Flavonoids, Baicalein, and Daidzein in Estrogenic and Neuroprotective Effects: A Development of Potential Health Products and Therapeutic Drugs against Alzheimer's Disease.

Authors:  Roy C Y Choi; Judy T T Zhu; Amanda W Y Yung; Pinky S C Lee; Sherry L Xu; Ava J Y Guo; Kevin Y Zhu; Tina T X Dong; Karl W K Tsim
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-24       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.